Abstract
β2-adrenergic receptors re abundantly expressed in airways, which explains the role of β2 agonists, the strongest bronchodilators, in treatment of bronchial constriction. There may be a relation between β2ADR gene polymorphism and the response to treatment with β2 agonists. In the present study we attempted to study these relationship in vivo, estimating spirometric values before and after the use of salbutamol in reference to variant of β2ADR gene polymorphisms. The study involved 148 healthy male volunteers. After the examination of the gene polymorphism of the β2-adrenergic receptor (β2-ADR) at nucleotide positions 46 and 79 (g.46 and g.79) we performed spirometry testing in all subjects. The pulmonary function was checked twice a day; before and 15 min after the administration of salbutamol. All subjects had normal basic values of spirometry. The use of salbutamol significantly increased spirometric values in all groups determined by β2ADR gene polymorphisms. Analysis of the spirometric values in individual groups showed a significant increase only in peak expiratory flow (g.46AA and g.79CC). The results of this study give an insight into a possibly important mechanism of the response to treatment with β2-agonists.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Thoracic Society. (1995). Standardization of spirometry 1994 update. American Journal of Respiratory and Critical Care Medicine, 152(3), 1107–1136.
Aziz, I., Hall, I. P., McFarlane, L. C., & Lipworth, B. J. (1998). β2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma. The Journal of Allergy and Clinical Immunology, 101(3), 337–341.
Barnes, P. J. (1995). β-adrenergic receptors and their regulation. American Journal of Respiratory and Critical Care Medicine, 152(3), 838–860.
Bouhuys, A., & van de Woestijne, K. P. (1971). Mechanical consequences of airway smooth muscle relaxation. Journal of Applied Physiology, 30(5), 670–676.
Brand, P., Quanjer, P. H., & Postma, D. S. (1992). Interpretation of bronchodilator response in patients with obstructive airways disease. Thorax, 47, 429–436.
Cho, S. H. (2010). Pharmacogenomic approaches to asthma treatment. Allergy, Asthma & Immunology Research, 2(3), 177–821.
Drysdale, C. M., McGraw, D. W., Stack, C. B., Stephens, J. C., Judson, R. S., Nandabalan, K., Arnold, K., Ruano, G., & Liggett, S. B. (2000). Complex promoter and coding region β2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proceedings of the National Academy of Sciences USA, 97(19), 10483–10488.
Green, A. S., Turki, J., Innis, M., & Liggett, S. B. (1994). Amino-terminal polymorphisms of the human β2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry, 33(32), 9414–9419.
Hein, L. (2001). Physiological significance of β-adrenergic receptor polymorphisms in vivo or in vitro veritas? Pharmacogenetics, 11(3), 187–189.
Holloway, J. W., Dunbar, P. R., Riley, G. A., Sawyer, G. M., Fitzharris, P. F., Pearce, N., Le Gros, G. S., & Beasley, R. (2000). Association of β2-adrenergic receptor polymorphisms with severe asthma. Clinical and Experimental Allergy, 30(8), 1097–1103.
Kotani, Y., Nishimura, Y., Maeda, H., & Yokoyama, M. (1999). β2-adrenergic receptor polymorphisms affect airway responsiveness to salbutamol in asthmatics. Journal of Asthma, 36(7), 583–590.
Lefkowitz, R. J., Hausdor, W. P., & Caron, M. G. (1990). Role of phosphorylation in desensitization of the beta adrenoreceptor. Trends in Pharmacological Sciences, 11, 190–194.
Liggett, S. B. (1997). Polymorphisms of the β2-adrenergic receptor and asthma. American Journal of Respiratory and Critical Care Medicine, 56, 156–162.
Liggett, S. B. (1998). Pharmacogenetics of relevant targets in asthma. Clinical and Experimental Allergy, 28(Suppl 1), 77–79.
Liggett, S. B. (2000). Pharmacogenetics of β1-and β2-adrenergic receptors. Pharmacology, 61(3), 167–173.
Lima, J. J., Thomason, D. B., Mohamed, M. H., Eberle, L. V., Self, T. H., & Johnson, J. A. (1999). Impact of genetic polymorphisms of the β2-adrenergic receptor on albuterol bronchdilator pharmacodynamics. Clinical Pharmacology and Therapeutics, 65(5), 519–525.
Martinez, F. D., Graves, P. E., & Baldini, M. (1997). Association between genetic polymorphisms of the β2-adrenoceptor and response to albuterol in children with and without a history of wheezing. Journal of Clinical Investigation, 100(12), 3184–3188.
McGraw, D. W., & Liggett, S. B. (1999). Coding block and 5′ leader cistron polymorphisms of the β2-adrenergic receptor. Clinical and Experimental Allergy, 29(Suppl. 4), 43–45.
Nakada, T. A., Russell, J. A., Boyd, J. H., Aguirre-Hernandez, R., Thain, K. R., Thair, S. A., Nakada, E., McConechy, M., & Walley, K. R. (2010). Beta2-adrenergic receptor gene polymorphism is associated with mortality in septic shock. American Journal of Respiratory and Critical Care Medicine, 181(2), 143–149.
Panebra, A., Wang, W. C., Malone, M. M., Pitter, D. R., Weiss, S. T., Hawkins, G. A., & Liggett, S. B. (2010). Common ADRB2 haplotypes derived from 26 polymorphic sites direct beta2-adrenergic receptor expression and regulation phenotypes. PLoS One, 5(7), e11819.
Poziomkowska-Gesicka, I., Dzieciolowska-Baran, E., Gawlikowska-Sroka, E., Slowik-Zylka, D., & Sroczynski, T. (2010). Evaluation of spirometry values in relation to beta2adrenergic receptor polymorphism. European Journal of Medical Research, 15(Suppl. II), 135–140.
Ramsay, C. E., Hayden, C. M., Tiller, K. J., Burton, P. R., Goldblatt, J., & Lesouef, P. N. (1999). Polymorphisms in the β2-ADR gene are associated with decreased airway responsiveness. Clinical and Experimental Allergy, 29(9), 1195–1203.
Santus, P., Pecchiari, M., Carlucci, P., Boveri, B., Di Marco, F., Castagna, F., & Centanni, S. (2003). Bronchodilation test in COPD: Effect of inspiratory manoeuvre preceding forced expiration. European Respiratory Journal, 21(1), 82–85.
Scott, M. G., Swan, C., Wheatley, A. P., & Hall, I. P. (1999). Identification of novel polymorphisms within the promoter region of the human β2-adrenergic receptor gene. British Journal of Pharmacology, 126(4), 841–844.
Small, K. M., McGraw, D. W., & Liggett, S. B. (2003). Pharmacology and physiology of human adrenergic receptor polymorphisms. Annual Review of Pharmacology and Toxicology, 43, 381–411.
Taylor, D. R., Drazen, J. M., & Herbison, G. P. (2000). The influence of polymorphism at position 16 of the β2-adrenoceptor on the development of tolerance to β-agonist. The Journal of Asthma, 37(8), 691–700.
Vacca, G., Schwabe, K., Dück, R., Hlawa, H. P., Westphal, A., Pabst, S., Grohé, C., & Gillissen, A. (2009). Polymorphisms of the beta2 adrenoceptor gene in chronic obstructive pulmonary disease. Therapeutic Advances in Respiratory Disease, 3(1), 3–10.
Watanabe, S., Renzetti, A. D., Jr., Begin, R., & Bigler, A. H. (1974). Airway responsiveness to a bronchodilator aerosol. American Review of Respiratory Disease, 109(5), 530–537.
Conflicts of Interest: The authors declare no conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this paper
Cite this paper
Poziomkowska-Gesicka, I. et al. (2013). β2-Adrenergic Receptor Gene Polymorphism and Response to Bronchodilating Treatment Evaluated by Spirometry. In: Pokorski, M. (eds) Respiratory Regulation - Clinical Advances. Advances in Experimental Medicine and Biology, vol 755. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4546-9_22
Download citation
DOI: https://doi.org/10.1007/978-94-007-4546-9_22
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4545-2
Online ISBN: 978-94-007-4546-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)